Dr Reddy’s Laboratories has been served a securities class action lawsuit in the US for alleged violations of federal securities laws.
The lawsuit, filed in the US district court of New Jersey, seeks damages to compensate investors for a purported decline in Dr Reddy’s share price caused by alleged misstatements or omissions by the company. The company is listed in the New York Stock Exchange besides Indian exchanges.
No comments:
Post a Comment